CD8A and neoplasm: Pretreatment with low doses of the DNA demethylating agent decitabine for two weeks enhanced the T cell response to PD-L1 blockade in Tramp-C2 tumor-bearing mice, inducing the expansion of tumor-infiltrating CD8+ T cells 74.